Q1 2022 Inhibikase Therapeutics Inc Earnings Call Transcript
Greetings. Welcome to Inhibikase Therapeutics' first-quarter 2022 financial results conference call. At this time, all participants are in listen-only mode. A question-and-answer session will follow the formal presentation. (Operator Instructions)
Please note this conference is being recorded.
I will now turn the conference over to Alex Lobo, Stern Investor Relations. Thank you. You may begin.
Thank you, Sherry. Good morning and welcome to Inhibikase Therapeutics' first-quarter 2022 financial results conference call and audio webcast.
With me today is Dr. Milton Werner, Chief Executive Officer; and Joseph Frattaroli, Chief Financial Officer.
Yesterday, Inhibikase issued a press release announcing financial results for the first quarter ended March 31, 2022. We encourage everyone to read yesterday's press release, as well as Inhibikase's quarterly report on Form 10-Q for the first-quarter 2022, which is being filed with the SEC. The company's press release and quarterly report are also available on
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |